| Literature DB >> 32676478 |
Masashi Utsumi1, Hideki Aoki1, Seiichi Nagahisa1, Seitaro Nishimura1, Yuta Une1, Yuji Kimura1, Megumi Watanabe1, Fumitaka Taniguchi1, Takashi Arata1, Koh Katsuda1, Kohji Tanakaya1.
Abstract
PURPOSE: Postoperative pancreatic fistula (POPF) is the most important factor affecting morbidity and mortality after pancreaticoduodenectomy (PD). Patients with a high controlling nutritional status (CONUT) score, which is used to assess nutritional status, are expected to have high morbidity rates. This study aimed to determine the usefulness of the CONUT score.Entities:
Keywords: CONUT score; Pancreatic fistula; Pancreaticoduodenectomy
Year: 2020 PMID: 32676478 PMCID: PMC7332320 DOI: 10.4174/astr.2020.99.1.18
Source DB: PubMed Journal: Ann Surg Treat Res ISSN: 2288-6575 Impact factor: 1.859
Assessment of undernutrition status by the CONUT score
CONUT, controlling nutritional status.
Clinical and preoperative characteristics of 97 patients in this study
Values are presented as number (%) or median (interquartile range).
IPMN, intraductal papillary mucinous neoplasm; SPN, solid-pseudopapillary neoplasm; AIP, autoimmune pancreatitis; PNET, pancreatic neuroendocrine tumor; CONUT, controlling nutritional status; MPD, main pancreatic duct; MRCP, magnetic resonance cholangiopancreatography; L/E ratio, late/early phase ratio.
a)According to the international Study Group of Pancreatic Fistula (ISGPF) classification.
Fig. 1Distribution of the controlling nutritional status (CONUT) scores.
Risk factors for pancreatic fistula according to univariate analysis
POPF, postoperative pancreatic fistula; CONUT, controlling nutritional status; MPD, main pancreatic duct; MRCP, magnetic resonance cholangiopancreatography; L/E ratio, late/early phase ratio.
Independent predictors of pancreatic fistula according to multivariate analysis
CI, confidence interval; CONUT, controlling nutritional status; L/E ratio, late/early phase ratio.
Fig. 2Proportion of postoperative pancreatic fistula to the scoring system. A simple scoring system for all patients was then developed, with 1 point assigned to each significant factor: body mass index ≥ 22 kg/m2, high controlling nutritional status score, nonpancreatic carcinoma, and CT attenuation values (L/E ratio) in the pancreatic body, using similar odds ratio to that is used in the multivariate analysis. The patients were divided into 4 groups according to the number of risk factors. L/E ratio, late/early phase ratio.